Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
In calculating the Net Current Asset Value (NCAV), Benjamin Graham means a company's current assets (such as cash, marketable securities, and inventories) minus its total liabilities (including preferred stock, minority interest, and long-term debt).
LBX Pharmacy Chain JSC's net current asset value per share for the quarter that ended in Mar. 2026 was ¥-5.39.
The historical rank and industry rank for LBX Pharmacy Chain JSC's Net Current Asset Value or its related term are showing as below:
During the past 13 years, the highest Price-to-Net-Current-Asset-Value Ratio of LBX Pharmacy Chain JSC was 3013.10. The lowest was 41.22. And the median was 73.33.
SHSE:603883's Price-to-Net-Current-Asset-Value is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 5.75 * Ranked among companies with meaningful Price-to-Net-Current-Asset-Value only.
LBX Pharmacy Chain JSC (SHSE:603883) Net Current Asset Value Explanation
Benjamin Graham first discussed net current asset value (NCAV) in the 1934 edition of "Security Analysis", which he coauthored with David Dodd. In the book, (net) current asset value is defined as:" current assets alone, minus all liabilities and claims ahead of the issue."
The common definition of NCAV is: NCAV = current assets – [total liabilities + minority interest + preferred stock]
Net current assets exclude not only the intangible assets but also the fixed and miscellaneous assets. In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. In "Security Analysis", preferred stock is dubbed "an imperfect creditorship position" that is best placed on the balance sheet alongside funded debt.
One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Grahams strategy produced similar results.
Benjamin Graham looked for companies whose market values were less than two-thirds of their Net-Net Working Capital. They are collected under our Net-Net screener.
LBX Pharmacy Chain JSC Net Current Asset Value Related Terms
LBX Pharmacy Chain JSC Net Current Asset Value Historical Data
* Premium members only.
The historical data trend for LBX Pharmacy Chain JSC's Net Current Asset Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LBX Pharmacy Chain JSC Net Current Asset Value Chart
LBX Pharmacy Chain JSC Net Current Asset Value Competitor Comparison
For the Pharmaceutical Retailers subindustry, LBX Pharmacy Chain JSC's Price-to-Net-Current-Asset-Value, along with its competitors' market caps and Price-to-Net-Current-Asset-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
LBX Pharmacy Chain JSC Price-to-Net-Current-Asset-Value vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, LBX Pharmacy Chain JSC's Price-to-Net-Current-Asset-Value distribution charts can be found below:
* The bar in red indicates where LBX Pharmacy Chain JSC's Price-to-Net-Current-Asset-Value falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Net Current Asset Value of ¥-5.39 mean?
LBX Pharmacy Chain JSC (SHSE:603883) has a Net Current Asset Value of ¥-5.39 as of Mar. 2026. Ben Graham's net current asset value equals the per-share value of total current assets less total liabilities. View historical data on LBX Pharmacy Chain JSC and its competitors. Over the past decade, LBX Pharmacy Chain JSC's Net Current Asset Value has ranged from 41.22 to 3,013.10. According to the industry distribution chart, LBX Pharmacy Chain JSC ranks #999999 out of 269 companies in the Healthcare Providers & Services industry.
Is LBX Pharmacy Chain JSC's Net Current Asset Value too high?
LBX Pharmacy Chain JSC's current Net Current Asset Value is ¥-5.39. Over the past 10 years, this metric has ranged from a low of 41.22 to a high of 3,013.10. Based on the distribution chart, LBX Pharmacy Chain JSC ranks #999999 out of 269 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, LBX Pharmacy Chain JSC has a GF Score™ of 80/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does LBX Pharmacy Chain JSC's Net Current Asset Value compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, LBX Pharmacy Chain JSC ranks #999999 out of 269 companies for Net Current Asset Value. This places LBX Pharmacy Chain JSC in the lower half of its industry. The industry median Net Current Asset Value is 5.75. Historically, LBX Pharmacy Chain JSC's own Net Current Asset Value has ranged from 41.22 to 3,013.10 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Current Asset Value for a Healthcare Providers & Services company?
The median Net Current Asset Value among Healthcare Providers & Services companies is 5.75, based on 269 companies in the industry. Companies in the top quartile (top 25%) have a Net Current Asset Value significantly above this median, while those in the bottom quartile fall well below. However, Net Current Asset Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Current Asset Value mean?
A high Net Current Asset Value can signal that a stock is expensive relative to its fundamentals. Ben Graham's net current asset value equals the per-share value of total current assets less total liabilities. View historical data on LBX Pharmacy Chain JSC and its competitors. For the Healthcare Providers & Services industry, the median Net Current Asset Value is 5.75 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. LBX Pharmacy Chain JSC's current Net Current Asset Value is ¥-5.39. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LBX Pharmacy Chain JSC stock overvalued right now?
Based on GuruFocus' analysis, LBX Pharmacy Chain JSC (SHSE:603883) is currently considered Significantly Undervalued. The stock's GF Value™ is ¥19.26, compared to a current price of ¥11.97 — trading 37.9% below its estimated fair value. The current Net Current Asset Value is ¥-5.39. LBX Pharmacy Chain JSC's overall GF Score™ is 80/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Current Asset Value calculated?
Net Current Asset Value is calculated from a company's financial statements. For LBX Pharmacy Chain JSC (SHSE:603883), the current Net Current Asset Value is ¥-5.39 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is LBX Pharmacy Chain JSC (SHSE:603883) Overvalued in 2026?
Based on GuruFocus' analysis, LBX Pharmacy Chain JSC stock appears to be undervalued.
The current stock price of ¥11.97 is trading 37.9% below its estimated GF Value™ of ¥19.26.
GuruFocus considers LBX Pharmacy Chain JSC to be Significantly Undervalued.
Key valuation signals for SHSE:603883:
Net Current Asset Value: ¥-5.39
GF Value™: ¥19.26 vs. price of ¥11.97 (37.9% below fair value)
No single metric tells the full story. See the SHSE:603883 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
LBX Pharmacy Chain JSC is a China-based company engages in the sale of medicine and health products. The company is engaged in retailing drugs and other related products, including Chinese and Western medicine, prepared slices of Chinese crude drugs, health equipment, healthy food, and personal care products and life care products. The company is also involved in the wholesale and manufacture of drugs.
80GF Score
Get the complete analysis for SHSE:603883
Net Current Asset Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:603883 has been successfully added to your 
